Radical prostatectomy (RP) remains a standard treatment option for clinically localized high-
risk prostate cancer. While RP provides excellent local control, patients with high-risk …

Purpose: Early treatment intensification with neoadjuvant therapy may improve outcomes in
patients with high-risk, localized prostate cancer treated with radical prostatectomy. Our …

Opinion statement Localized high-risk (HR) prostate cancer (PCa) is a heterogenous
disease state with a wide range of presentations and outcomes. Historically, non-surgical …

Background: Biochemical recurrence (BCR) represents the rise of prostate-specific antigen
(PSA) levels after treatment with curative radical prostatectomy (RP) or radiation for prostate …

Background and objective Recently, deep learning algorithms, including convolutional
neural networks (CNNs), have shown remarkable progress in medical imaging analysis …

Objectives To test the effect of race/ethnicity on cancer‐specific mortality after radical
prostatectomy or external beam radiotherapy in localized prostate cancer patients. Methods …

Sociodemographic and lifestyle factors may play a role in determining whether patients with
clinically localized prostate cancer (PC) are managed with active surveillance (AS), radical …

Background Contemporary seminal vesicle invasion (SVI) rates in National Cancer
Comprehensive Network (NCCN) high‐risk prostate cancer (PCa) patients are not well …

Objective: The aim of this study was to test for the association between lymphovascular
invasion or perineural invasion in radical prostatectomy (RP) specimens and biochemical …

Purpose To investigate pathological stage at radical prostatectomy (RP) using the “Partin
tables” approach in NCCN high-risk (HR) prostate cancer (PCa) patients. Materials and …